Nancy Olivieri

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
O'Donnell A; Premawardhena A; Arambepola M; Samaranayake R; Allen S J; Peto T E A; Fisher C A; Cook J; Corran P H; Olivieri Nancy F; Weatherall D J
Interaction of malaria with a common form of severe thalassemia in an Asian population.
Fung Ellen B; Harmatz Paul R; Milet Meredith; Balasa Vinod; Ballas Samir K; Casella James F; Hilliard Lee; Kutlar Abdullah; McClain Kenneth L; Olivieri Nancy F; Porter John B; Vichinsky Elliott P;
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
Olivieri Nancy F; Muraca Giulia M; O'Donnell Angela; Premawardhena Anuja; Fisher Christopher; Weatherall David J
Studies in haemoglobin E beta-thalassaemia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nancy Olivieri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: O'Donnell A; Premawardhena A; Arambepola M; Samaranayake R; Allen S J; Peto T E A; Fisher C A; Cook J; Corran P H; Olivieri Nancy F; Weatherall D J
Interaction of malaria with a common form of severe thalassemia in an Asian population.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(44):18716-21.
2008: Fung Ellen B; Harmatz Paul R; Milet Meredith; Balasa Vinod; Ballas Samir K; Casella James F; Hilliard Lee; Kutlar Abdullah; McClain Kenneth L; Olivieri Nancy F; Porter John B; Vichinsky Elliott P;
Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
Transfusion 2008;48(9):1971-80.
2008: Olivieri Nancy F; Muraca Giulia M; O'Donnell Angela; Premawardhena Anuja; Fisher Christopher; Weatherall David J
Studies in haemoglobin E beta-thalassaemia.
British journal of haematology 2008;141(3):388-97.
2008: Porter John; Galanello Renzo; Saglio Giuseppe; Neufeld Ellis J; Vichinsky Elliott; Cappellini Maria Domenica; Olivieri Nancy; Piga Antonio; Cunningham Melody J; Soulières Denis; Gattermann Norbert; Tchernia Gilbert; Maertens Johan; Giardina Patricia; Kwiatkowski Janet; Quarta Giovanni; Jeng Michael; Forni Gian Luca; Stadler Michael; Cario Holger; Debusscher Louisette; Della Porta Matteo; Cazzola Mario; Greenberg Peter; Alimena Giuliana; Rabault Bertrand; Gathmann Insa; Ford John Malcolm; Alberti Daniele; Rose Christian
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.
European journal of haematology 2008;80(2):168-76.
2007: O'Donnell Angela; Premawardhena A; Arambepola M; Allen S J; Peto T E A; Fisher C A; Rees D C; Olivieri Nancy F; Weatherall D J
Age-related changes in adaptation to severe anemia in childhood in developing countries.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(22):9440-4.
2007: Fung Ellen B; Harmatz Paul; Milet Meredith; Ballas Samir K; De Castro Laura; Hagar Ward; Owen William; Olivieri Nancy; Smith-Whitley Kim; Darbari Deepika; Wang Winfred; Vichinsky Elliott;
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
American journal of hematology 2007;82(4):255-65.
2006: Sloane-Stanley Jackie; Roberts Nigel A; Olivieri Nancy; Weatherall David J; Wood William G
Globin gene expression in Hb Lepore-BAC transgenic mice.
British journal of haematology 2006;135(5):735-7.
2006: Vogiatzi M G; Macklin E A; Fung E B; Vichinsky E; Olivieri N; Kwiatkowski J; Cohen A; Neufeld E; Giardina P J
Prevalence of fractures among the Thalassemia syndromes in North America.
Bone 2006;38(4):571-5.
2005: Vichinsky Elliott P; MacKlin Eric A; Waye John S; Lorey Fred; Olivieri Nancy F
Changes in the epidemiology of thalassemia in North America: a new minority disease.
Pediatrics 2005;116(6):e818-25.
2005: Premawardhena Anuja; Fisher Christopher A; Olivieri Nancy F; de Silva Shanthimala; Sloane-Stanley Jackie; Wood William G; Weatherall David J
A novel molecular basis for beta thalassemia intermedia poses new questions about its pathophysiology.
Blood 2005;106(9):3251-5.
2005: Premawardhena A; Fisher C A; Olivieri N F; de Silva S; Arambepola M; Perera W; O'Donnell A; Peto T E A; Viprakasit V; Merson L; Muraca G; Weatherall D J
Haemoglobin E beta thalassaemia in Sri Lanka.
Lancet 2005;366(9495):1467-70.
2005: Sheth Sujit; Tang Haiying; Jensen Jens H; Altmann Karen; Prakash Ashwin; Printz Beth F; Hordof Alan J; Tosti Christina L; Azabagic Andjela; Swaminathan Srirama; Brown Truman R; Olivieri Nancy F; Brittenham Gary M
Methods for noninvasive measurement of tissue iron in Cooley's anemia.
Annals of the New York Academy of Sciences 2005;1054():358-72.
2005: Premawardhena Anuja; De Silver Shanthimala; Arambepola Mahinda; Olivieri Nancy F; Vichinsky Elliott P; Merson Laura; Muraco Giulia; Allen Angela; Fisher Christopher; Peto Timothy; Weatherall David J
Hemoglobin E-beta-thalassemia: Progress report from the International Study Group.
Annals of the New York Academy of Sciences 2005;1054():33-9.
2004: Premawardhena Anuja; De Silva Shanthimala; Arambepola Mahinda; Olivieri Nancy; Merson Laura; Muraco Julia; Allen Angela; Fisher Christopher; Peto Timothy; Vichinsky Elliot; Weatherall David
Thalassemia in Sri Lanka: a progress report.
Human molecular genetics 2004;13 Spec No 2():R203-6.
2003: Brittenham Gary M; Nathan David G; Olivieri Nancy F; Porter John B; Pippard Martin; Vichinsky Elliott P; Weatherall David J
Deferiprone and hepatic fibrosis.
Blood 2003;101(12):5089-90; author reply 5090-1.
2003: Nisbet-Brown Eric; Olivieri Nancy F; Giardina Patricia J; Grady Robert W; Neufeld Ellis J; Séchaud Romain; Krebs-Brown Axel J; Anderson Judith R; Alberti Daniele; Sizer Kurt C; Nathan David G
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.
Lancet 2003;361(9369):1597-602.
2003: Brittenham G M; Nathan D G; Olivieri N F; Pippard M J; Weatherall D J
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.
Lancet 2003;361(9352):183; author reply 183-4.
2001: Waye J S; Eng B; Patterson M; Carcao M D; Chang L; Olivieri N F; Chui D H
Identification of two new alpha-thalassemia mutations in exon 2 of the alpha1-globin gene.
Hemoglobin 2001;25(4):391-6.
2001: Waye J S; Eng B; Patterson M; Walker L; Carcao M D; Olivieri N F; Chui D H
Hemoglobin H (Hb H) disease in Canada: molecular diagnosis and review of 116 cases.
American journal of hematology 2001;68(1):11-5.
2001: Premawardhena A; Fisher C A; Fathiu F; de Silva S; Perera W; Peto T E; Olivieri N F; Weatherall D J
Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.
Lancet 2001;357(9272):1945-6.
2001: Olivieri N F
Progression of iron overload in sickle cell disease.
Seminars in hematology 2001;38(1 Suppl 1):57-62.
2000: Olivieri N F; De Silva S; Premawardena A; Sharma S; Viens A M; Taylor C M; Brittenham G M; Weatherall D J
Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2000;22(6):593-7.
2000: de Silva S; Fisher C A; Premawardhena A; Lamabadusuriya S P; Peto T E; Perera G; Old J M; Clegg J B; Olivieri N F; Weatherall D J
Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group.
Lancet 2000;355(9206):786-91.
1999: Carcao M D; Chang L; Poon A; Olivieri N F; Waye J S; Eng B; Patterson M; Chui D H
Compound heterozygosity for Hb S and Hb G-Copenhagen.
Hemoglobin 1999;23(4):379-81.
1999: Olivieri N F
The beta-thalassemias.
The New England journal of medicine 1999;341(2):99-109.
1998: Olivieri N F; Brittenham G M; McLaren C E; Templeton D M; Cameron R G; McClelland R A; Burt A D; Fleming K A
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.
The New England journal of medicine 1998;339(7):417-23.
1998: Klein N; Sen A; Rusby J; Ratip S; Modell B; Olivieri N F
The psychosocial burden of Cooley's anemia in affected children and their parents.
Annals of the New York Academy of Sciences 1998;850():512-3.
1998: Saxon B R; Waye J S; Olivieri N F
Increase in hemoglobin concentration during therapy with hydroxyurea in Cooley's anemia.
Annals of the New York Academy of Sciences 1998;850():459-60.
1998: MacMillan M L; Fouladi M; Nisbet-Brown E; Waye J S; Olivieri N F
Treatment of two infants with Cooley's anemia with sodium phenylbutyrate.
Annals of the New York Academy of Sciences 1998;850():452-4.
1998: Fouladi M; Macmillan M L; Nisbet-Brown E; Klein N; Barlas J; Waye J S; Olivieri N F
Hemoglobin E/beta thalassemia: the Canadian experience.
Annals of the New York Academy of Sciences 1998;850():410-1.
1998: Olivieri N F; Brittenham G M
Long-term trials of deferiprone in Cooley's anemia.
Annals of the New York Academy of Sciences 1998;850():217-22.
1998: Olivieri N F; Rees D C; Ginder G D; Thein S L; Waye J S; Chang L; Brittenham G M; Weatherall D J
Elimination of transfusions through induction of fetal hemoglobin synthesis in Cooley's anemia.
Annals of the New York Academy of Sciences 1998;850():100-9.
1998: Saxon B R; Rees D; Olivieri N F
Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in beta thalassaemia.
British journal of haematology 1998;101(3):416-9.
1998: Olivieri N
Thalassaemia: clinical management.
Baillière's clinical haematology 1998;11(1):147-62.
1998: Thuma P E; Olivieri N F; Mabeza G F; Biemba G; Parry D; Zulu S; Fassos F F; McClelland R A; Koren G; Brittenham G M; Gordeuk V R
Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans.
The American journal of tropical medicine and hygiene 1998;58(3):358-64.
1998: Olivieri N F; Vichinsky E P
Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1998;20(1):26-31.
1998: Olivieri N F; Weatherall D J
The therapeutic reactivation of fetal haemoglobin.
Human molecular genetics 1998;7(10):1655-8.
1997: Loebstein R; Dalal I; Nisbet-Brown E; Berkovitch M; Meydan N; Andrews D; Loubser M D; Koren G; Roifman C M; Olivieri N F
Immune function in patients with beta thalassaemia receiving the orally active iron-chelating agent deferiprone.
British journal of haematology 1997;98(3):597-600.
1997: Waye J S; Eng B; Patterson M; Chui D H; Nisbet-Brown E; Olivieri N F
Novel mutation of the alpha 2-globin gene initiation codon (ATG-->A-G) in a Vietnamese girl with Hb H disease.
Hemoglobin 1997;21(5):469-72.
1997: Shilalukey K; Kaufman M; Bradley S; Francombe W H; Amankwah K; Goldberg E; Shear N; Olivieri N F; Koren G
Counseling sexually active teenagers treated with potential human teratogens.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 1997;21(3):143-6.
1997: Olivieri N F; Rees D C; Ginder G D; Thein S L; Brittenham G M; Waye J S; Weatherall D J
Treatment of thalassaemia major with phenylbutyrate and hydroxyurea.
Lancet 1997;350(9076):491-2.
1997: Selby R; Nisbet-Brown E; Basran R K; Chang L; Olivieri N F
Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease.
Blood 1997;90(2):891-3.
1997: Parkes J G; Olivieri N F; Templeton D M
Characterization of Fe2+ and Fe3+ transport by iron-loaded cardiac myocytes.
Toxicology 1997;117(2-3):141-51.
1997: Olivieri N F; Brittenham G M
Iron-chelating therapy and the treatment of thalassemia.
Blood 1997;89(3):739-61.
1996: Fassos F F; Klein J; Fernandes D; Matsui D; Olivieri N F; Koren G
The pharmacokinetics and pharmacodynamics of the oral iron chelator deferiprone (L1) in relation to hemoglobin levels.
International journal of clinical pharmacology and therapeutics 1996;34(7):288-92.
1996: Olivieri N F
Orally active iron chelators in the treatment of iron overload.
Current opinion in hematology 1996;3(2):125-30.
1996: Olivieri N F
Reactivation of fetal hemoglobin in patients with beta-thalassemia.
Seminars in hematology 1996;33(1):24-42.
1996: Olivieri N F
Long-term therapy with deferiprone.
Acta haematologica 1996;95(1):37-48.
1995: Waye J S; Eng B; Patterson M; Wasi P; Chui D H; Francombe W H; Sher G D; Olivieri N F
Severity of beta-thalassemia due to genotypes involving the IVS-I-6 (T-->C) mutation.
American journal of hematology 1995;50(1):15-9.
1995: Sher G D; Ginder G D; Little J; Yang S; Dover G J; Olivieri N F
Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
The New England journal of medicine 1995;332(24):1606-10.
1995: Olivieri N F; Brittenham G M; Matsui D; Berkovitch M; Blendis L M; Cameron R G; McClelland R A; Liu P P; Templeton D M; Koren G
Iron-chelation therapy with oral deferipronein patients with thalassemia major.
The New England journal of medicine 1995;332(14):918-22.
1995: Parkes J G; Randell E W; Olivieri N F; Templeton D M
Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
Biochimica et biophysica acta 1995;1243(3):373-80.
1995: Berkovitch M; Davis S; Matsui D; Donsky J; Koren G; Olivieri N F
Use of a eutectic mixture of local anesthetics for prolonged subcutaneous drug administration.
Journal of clinical pharmacology 1995;35(3):295-7.
1995: Larochelle A; Vormoor J; Lapidot T; Sher G; Furukawa T; Li Q; Shultz L D; Olivieri N F; Stamatoyannopoulos G; Dick J E
Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols.
Human molecular genetics 1995;4(2):163-72.
1994: Waye J S; Eng B; Patterson M; Chui D H; Chang L S; Cogionis B; Poon A O; Olivieri N F
Hb E/Hb LeporeHollandia in a family from Bangladesh.
American journal of hematology 1994;47(4):262-5.
1994: Waye J S; Eng B; Olivieri N F; Chui D H
Identification of a novel beta O-thalassaemia mutation in a Greek family and subsequent prenatal diagnosis.
Prenatal diagnosis 1994;14(10):929-32.
1994: Olivieri N F; Nathan D G; MacMillan J H; Wayne A S; Liu P P; McGee A; Martin M; Koren G; Cohen A R
Survival in medically treated patients with homozygous beta-thalassemia.
The New England journal of medicine 1994;331(9):574-8.
1994: Waye J S; Patterson M; Eng B; Chui D H; Sher G D; Olivieri N F
DNA diagnosis of Hb S and Hb Caribbean (alpha 2 beta 2 91 Leu-->Arg) in a Jamaican family.
American journal of hematology 1994;47(1):33-5.
1994: Randell E W; Parkes J G; Olivieri N F; Templeton D M
Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron.
The Journal of biological chemistry 1994;269(23):16046-53.
1994: Collins A F; Gonçalves-Dias C; Haddad S; Talbot R; Herst R; Tyler B J; Zuber E; Blanchette V S; Olivieri N F
Comparison of a transfusion preparation of newly formed red cells and standard washed red cell transfusions in patients with homozygous beta-thalassemia.
Transfusion 1994;34(6):517-20.
1994: Berkovitch M; Laxer R M; Inman R; Koren G; Pritzker K P; Fritzler M J; Olivieri N F
Arthropathy in thalassaemia patients receiving deferiprone.
Lancet 1994;343(8911):1471-2.
1994: Olivieri N F; Feig S A; Valentino L; Berriman A M; Shore R; Freedman M H
Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia.
Blood 1994;83(9):2444-50.
1994: Collins A F; Fassos F F; Stobie S; Lewis N; Shaw D; Fry M; Templeton D M; McClelland R A; Koren G; Olivieri N F
Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease.
Blood 1994;83(8):2329-33.
1994: Olivieri N F; Liu P P; Sher G D; Daly P A; Greig P D; McCusker P J; Collins A F; Francombe W H; Templeton D M; Butany J
Brief report: combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia.
The New England journal of medicine 1994;330(16):1125-7.
1994: Perrine S P; Olivieri N F; Faller D V; Vichinsky E P; Dover G J; Ginder G D
Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
The American journal of pediatric hematology/oncology 1994;16(1):67-71.
1994: Fassos F F; Klein J; Fernandes D; Matsui D; Olivieri N F; Koren G
Urinary iron excretion depends on the mode of administration of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with homozygous beta-thalassemia.
Clinical pharmacology and therapeutics 1994;55(1):70-5.
1994: Krishnan S; Sturtridge W C; Olivieri N F; Collins A F; Qureshi R Y; Krishnan M; Belluzzo N; Bogdanovich E; Lui S M
A study on children's condition thalassemia using neutron activation analysis and other techniques.
Biological trace element research 1994;43-45():309-14.
1993: Parkes J G; Hussain R A; Olivieri N F; Templeton D M
Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells.
The Journal of laboratory and clinical medicine 1993;122(1):36-47.
1993: Perrine S P; Ginder G D; Faller D V; Dover G H; Ikuta T; Witkowska H E; Cai S P; Vichinsky E P; Olivieri N F
A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
The New England journal of medicine 1993;328(2):81-6.
1993: Olivieri N F; Matsui D; Liu P P; Blendis L; Cameron R; McClelland R A; Templeton D M; Koren G
Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients.
Bone marrow transplantation 1993;12 Suppl 1():9-11.
1993: Eng B; Chui D H; Saunderson J; Olivieri N F; Waye J S
Identification of two novel beta zero-thalassemia mutations in a Filipino family: frameshift codon 67 (-TG) and a beta-globin gene deletion.
Human mutation 1993;2(5):375-9.
1992: Olivieri N F; Freedman M H; Perrine S P; Dover G J; Sheridan B; Essentine D L; Nagel R L
Trial of recombinant human erythropoietin: three patients with thalassemia intermedia.
Blood 1992;80(12):3258-60.
1992: Robieux I C; Kellner J D; Coppes M J; Shaw D; Brown E; Good C; O'Brodovich H; Manson D; Olivieri N F; Zipursky A
Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation.
Pediatric hematology and oncology 1992;9(4):317-26.
1992: Olivieri N F; Berriman A M; Tyler B J; Davis S A; Francombe W H; Liu P P
Reduction in tissue iron stores with a new regimen of continuous ambulatory intravenous deferoxamine.
American journal of hematology 1992;41(1):61-3.
1992: Stuhne-Sekalec L; Xu S X; Parkes J G; Olivieri N F; Templeton D M
Speciation of tissue and cellular iron with on-line detection by inductively coupled plasma-mass spectrometry.
Analytical biochemistry 1992;205(2):278-84.
1992: Zipursky A; Robieux I C; Brown E J; Shaw D; O'Brodovich H; Kellner J D; Coppes M J; Koren G; Olivieri N F
Oxygen therapy in sickle cell disease.
The American journal of pediatric hematology/oncology 1992;14(3):222-8.
1992: Olivieri N F; Koren G; Matsui D; Liu P P; Blendis L; Cameron R; McClelland R A; Templeton D M
Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia.
Blood 1992;79(10):2741-8.
1992: Miller B A; Perrine S P; Bernstein A; Lyman S D; Williams D E; Bell L L; Olivieri N F
Influence of steel factor on hemoglobin synthesis in sickle cell disease.
Blood 1992;79(7):1861-8.
1992: Cai S P; Eng B; Francombe W H; Olivieri N F; Kendall A G; Waye J S; Chui D H
Two novel beta-thalassemia mutations in the 5' and 3' noncoding regions of the beta-globin gene.
Blood 1992;79(5):1342-6.
1992: Olivieri N F; Koren G; Harris J; Khattak S; Freedman M H; Templeton D M; Bailey J D; Reilly B J
Growth failure and bony changes induced by deferoxamine.
The American journal of pediatric hematology/oncology 1992;14(1):48-56.
1991: Olivieri N F; Matsui D; Hermann C; Koren G
Compliance assessed by the Medication Event Monitoring System.
Archives of disease in childhood 1991;66(12):1399-402.
1991: Olivieri N F; Grunberger T; Ben-David Y; Ng J; Williams D E; Lyman S; Anderson D M; Axelrad A A; Correa P; Bernstein A
Diamond-Blackfan anemia: heterogenous response of hematopoietic progenitor cells in vitro to the protein product of the steel locus.
Blood 1991;78(9):2211-5.
1991: Koren G; Kochavi-Atiya Y; Bentur Y; Olivieri N F
The effects of subcutaneous deferoxamine administration on renal function in thalassemia major.
International journal of hematology 1991;54(5):371-5.
1991: Cai S P; Chui D H; Ng J; Poon A O; Freedman M H; Olivieri N F
A new frameshift beta zero-thalassemia mutation (codons 27-28 +C) found in a Chinese family.
American journal of hematology 1991;37(1):6-8.
1991: Ward M A; Olivieri N F; Ng J; Roder J C
Detection of beta-thalassemia using an artificial-restriction fragment length polymorphism generated by the polymerase chain reaction.
Nucleic acids research 1991;19(4):959.
1990: Olivieri N F; Koren G; Hermann C; Bentur Y; Chung D; Klein J; St Louis P; Freedman M H; McClelland R A; Templeton D M
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
Lancet 1990;336(8726):1275-9.
1990: Bronspiegel-Weintrob N; Olivieri N F; Tyler B; Andrews D F; Freedman M H; Holland F J
Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major.
The New England journal of medicine 1990;323(11):713-9.
1990: Olivieri N F; Koren G; St Louis P; Freedman M H; McClelland R A; Templeton D M
Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients.
Seminars in hematology 1990;27(2):101-4.
1990: Olivieri N F; Templeton D M; Koren G; Chung D; Hermann C; Freedman M H; McClelland R A
Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients.
Annals of the New York Academy of Sciences 1990;612():369-77.
1989: Olivieri N F; Grisaru D; Daneman A; Martin D J; Rose V; Freedman M H
Computed tomography scanning of the liver to determine efficacy of iron chelation therapy in thalassemia major.
The Journal of pediatrics 1989;114(3):427-30.
1987: Olivieri N F; Chang L S; Poon A O; Michelson A M; Orkin S H
An alpha-globin gene initiation codon mutation in a black family with HbH disease.
Blood 1987;70(3):729-32.
1985: Wong S C; Chang L S; Olivieri N F; Poon A O; Ali M A; Groves D J
Compound heterozygosity for two genotypes of alpha-thalassemia-2: hematological, biosynthetic and DNA studies.
Hemoglobin 1985;9(2):111-26.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Nancy Olivieri

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Anatomy

Living Beings

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Nancy Olivieri (preview)

All Publications